Literature DB >> 24442075

Pseudo-outbreak of Klebsiella oxytoca spontaneous bacterial peritonitis attributed to contamination of multidose vials of culture medium supplement.

Federico Perez1, Abhishek Deshpande, Sirisha Kundrapu, Andrea M Hujer, Robert A Bonomo, Curtis J Donskey.   

Abstract

OBJECTIVE: To determine the source of a cluster of Klebsiella oxytoca isolates cultured from peritoneal fluid of 3 patients with cirrhosis on a single day.
DESIGN: Outbreak investigation and before-after study.
SETTING: A Veterans Affairs medical center.
METHODS: Epidemiologic investigation, analysis of antimicrobial susceptibility testing results and molecular typing of K. oxytoca isolates with repetitive sequence-based polymerase chain reaction (rep-PCR), review of microbiology laboratory procedures for processing peritoneal fluid cultures, and comparison of peritoneal fluid contamination rates 18 months before and after modification of laboratory procedures for culturing peritoneal fluid.
RESULTS: Each of the peritoneal fluid samples that grew K. oxytoca was inoculated into blood culture bottles by different clinicians at different hospital locations. None of the patients had clinical findings suggestive of peritonitis or elevated polymorphonuclear cell counts in peritoneal fluid (range, 3-25 cells/μL). Molecular typing with rep-PCR demonstrated that the K. oxytoca isolates were genetically related (greater than 95% similarity). Laboratory procedures included the routine addition of a culture medium supplement of yeast extract and dextrose from a multidose vial into blood culture bottles with peritoneal fluid. After discontinuing use of the culture medium supplement, there was a marked reduction in the number of peritoneal fluid cultures deemed as contaminants (14.3% vs 0.9%; [Formula: see text]).
CONCLUSION: A pseudo-outbreak of K. oxytoca peritonitis and high rates of contamination of peritoneal fluid were attributable to contamination of a multidose culture medium supplement. This article highlights the importance of discouraging the use of multidose vials in all clinical settings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24442075      PMCID: PMC3957413          DOI: 10.1086/674857

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  16 in total

1.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  Pseudo-outbreak of Bordetella bronchiseptica infection associated with contaminated rabbit blood used as a broth culture supplement.

Authors:  David P Calfee; John Kornblum; Stephen G Jenkins
Journal:  Infect Control Hosp Epidemiol       Date:  2007-04-27       Impact factor: 3.254

3.  Pseudo-outbreak of Rhizobium radiobacter infection resulting from laboratory contamination of saline solution.

Authors:  Lynette A Pereira; Douglas Su Gin Chan; Toon Mae Ng; Raymond Lin; Roland Jureen; Dale A Fisher; Paul A Tambyah
Journal:  J Clin Microbiol       Date:  2009-05-20       Impact factor: 5.948

4.  Comparison of BACTEC Plus 26 and 27 media with and without fastidious organism supplement with conventional methods for culture of sterile body fluids.

Authors:  D D Fuller; T E Davis; P C Kibsey; L Rosmus; L W Ayers; M Ott; M A Saubolle; D L Sewell
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

5.  Pseudo-outbreak of septicemia due to rapidly growing mycobacteria associated with extrinsic contamination of culture supplement.

Authors:  D A Ashford; S Kellerman; M Yakrus; S Brim; R C Good; L Finelli; W R Jarvis; M M McNeil
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

6.  Outbreak of adverse reactions associated with contaminated heparin.

Authors:  David B Blossom; Alexander J Kallen; Priti R Patel; Alexis Elward; Luke Robinson; Ganpan Gao; Robert Langer; Kiran M Perkins; Jennifer L Jaeger; Katie M Kurkjian; Marilyn Jones; Sarah F Schillie; Nadine Shehab; Daniel Ketterer; Ganesh Venkataraman; Takashi Kei Kishimoto; Zachary Shriver; Ann W McMahon; K Frank Austen; Steven Kozlowski; Arjun Srinivasan; George Turabelidze; Carolyn V Gould; Matthew J Arduino; Ram Sasisekharan
Journal:  N Engl J Med       Date:  2008-12-03       Impact factor: 91.245

Review 7.  Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results?

Authors:  Camilla L Wong; Jayna Holroyd-Leduc; Kevin E Thorpe; Sharon E Straus
Journal:  JAMA       Date:  2008-03-12       Impact factor: 56.272

8.  Pseudo-outbreak of Mycobacterium abscessus Infection Caused by laboratory contamination .

Authors:  D B Blossom; K A Alelis; D C Chang; A H Flores; J Gill; D Beall; A M Peterson; B Jensen; J Noble-Wang; M Williams; M A Yakrus; M J Arduino; A Srinivasan
Journal:  Infect Control Hosp Epidemiol       Date:  2008-01       Impact factor: 3.254

9.  Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.

Authors:  Andrea Endimiani; Andrea M Hujer; Federico Perez; Christopher R Bethel; Kristine M Hujer; Jennifer Kroeger; Margret Oethinger; David L Paterson; Mark D Adams; Michael R Jacobs; Daniel J Diekema; Gerri S Hall; Stephen G Jenkins; Louis B Rice; Fred C Tenover; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2009-01-20       Impact factor: 5.790

10.  Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.

Authors:  Joseph S Solomkin; John E Mazuski; John S Bradley; Keith A Rodvold; Ellie J C Goldstein; Ellen J Baron; Patrick J O'Neill; Anthony W Chow; E Patchen Dellinger; Soumitra R Eachempati; Sherwood Gorbach; Mary Hilfiker; Addison K May; Avery B Nathens; Robert G Sawyer; John G Bartlett
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.